Form D · Biotechnology
1859, Inc.
San Diego, CA · CIK 0001781857
Offering snapshot reported Nov 19, 2021 · SEC filing
- Reported sold
- $40M Offering amount: $40M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 17, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 19, 2021 | Initial | $39,999,995 | No comparison | 7 | SEC filing |
| Oct 12, 2021 | Initial | $2,000,000 | No comparison | 3 | SEC filing |
| Sep 16, 2021 | Amendment | $9,713,740 | $1,999,998vs Aug 25, 2020 | 8 | SEC filing |
| Aug 25, 2020 | Initial | $7,713,742 | No comparison | 8 | SEC filing |
| Jul 8, 2019 | Initial | $500,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-421894
Source: Form D, filed Nov 19, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Devon Cayer | Director, Executive |
| Paul Conley | Director |
| John Drewry | Director |
| Dan Faro | Director |
| Lily Li | Director |
| Andrew Mac Connell | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11425 Sorrento Valley Blvd, Suite 2
San Diego, CA, 92121
San Diego, CA, 92121